Crohns Disease

Crohns Disease is a chronic inflammatory disease, affecting the whole of the alimentary tract from mouth to anus, and all layers of the gut wall. The most commonly affected sites are the terminal il...

Human medicines European Public Assessment Report (EPAR): Mycophenolate mofetil Teva, mycophenolate mofetil, Revision: 10, Authorised

Connective tissue diseases: Interstitial lung disease treated with mycophenolate mofetil

Human medicines European Public Assessment Report (EPAR): Myfenax, mycophenolate mofetil, Revision: 10, Authorised

Human medicines European Public Assessment Report (EPAR): CellCept, mycophenolate mofetil, Revision: 20, Authorised

Human medicines European Public Assessment Report (EPAR): CellCept, mycophenolate mofetil, Revision: 21, Authorised

Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation

Equivalence of generic immunosuppressants

There are no compelling pharmacological arguments against the sensible use of the generic immunosuppressants ciclosporin, tacrolimus and mycophenolate mofetil in clinical practice, argue pharmacologis...

FDA unveils REMS for mycophenolate drugs

FDA approved a single REMS for all immunosuppressants containing mycophenolate to address the risks of first-trimester miscarriage and congenital birth defects. The REMS includes an education program...

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.

To describe effectiveness, steroid-sparing effect, and tolerance of the antiproliferative immunosuppressant mycophenolate mofetil (MMF) in neurosarcoidosis.

Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.

This study tested whether immunosuppression with mycophenolate mofetil (MMF) inhibits atherosclerosis development in apolipoprotein-E-deficient (Apoe(-/-)) mice and investigated the mechanism.

Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series.

Background: Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis. Objective: To describe the ou...

Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.

Background  Mycophenolate mofetil (MMF) has been lately proposed as one of the most promising steroid-sparing agent in pemphigus. Objective  To compare effectiveness and adverse events of two diff...

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials.

Introduction: Whether mycophenolate mofetil is superior to cyclophosphamide as induction therapy for lupus nephritis (LN) remains controversial. Objective: Our objective was to investigate the efficac...